COORDINATE EXPRESSION OF THE ALPHA-6 INTEGRIN LAMININ RECEPTOR SUBUNIT AND LAMININ IN BREAST-CANCER

被引:72
作者
DARDENNE, AJ [1 ]
RICHMAN, PI [1 ]
HORTON, MA [1 ]
MCAULAY, AE [1 ]
JORDAN, S [1 ]
机构
[1] ST BARTHOLOMEWS HOSP,IMPERIAL CANC RES FUND,HAEMOPOIESIS GRP,LONDON EC1A 7BE,ENGLAND
关键词
INTEGRINS; ALPHA-6; INTEGRIN; LAMININ RECEPTOR; LAMININ; BREAST CANCER; IMMUNOHISTOLOGY;
D O I
10.1002/path.1711650304
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Interactions between cells and extracellular matrices are mediated in part by a family of heterodimeric molecules known as integrins. We have investigated, using immunohistology, the distribution of six integrin alpha sub-units in normal breast tissue and 26 breast carcinomas. Alpha-1 integrin (collagen/laminin receptor sub-unit) was detected in myoepithelium, but not in luminal epithelium nor in most (20/26) carcinomas. Its expression on fibroblasts was enhanced in desmoplastic stroma. Both benign and malignant epithelium showed uniform positive staining for alpha-2 (collagen receptor sub-unit) and for alpha-3 (collagen/fibronectin/laminin receptor sub-unit). All epithelium was negative for alpha-4 (sub-unit of a fibronectin receptor). Epithelial staining for alpha-5 (fibronectin receptor sub-unit) was weak in all samples. Alpha-6 (sub-unit of two integrin laminin receptors) showed conspicuous changes in all invasive carcinomas. In normal tissues, there was weak staining of epithelial cytoplasm with alpha-6 antibody and moderate cell membrane staining. Strongest staining was present in a basement membrane distribution. In carcinomas, loss of cytoplasmic and cell membrane staining was variable, but basal membrane staining was diminished or absent in all tumours. Loss of basal membrane staining for alpha-6 integrin corresponded closely to loss of immunoreactivity for its ligand laminin in invasive breast cancer.
引用
收藏
页码:213 / 220
页数:8
相关论文
共 33 条
[1]   IMMUNOHISTOCHEMICAL DETECTION OF LAMININ IN 98 HUMAN-BREAST CARCINOMAS - A LIGHT AND ELECTRON-MICROSCOPIC STUDY [J].
CHARPIN, C ;
LISSITZKY, JC ;
JACQUEMIER, J ;
LAVAUT, MN ;
KOPP, F ;
POURREAUSCHNEIDER, N ;
MARTIN, PM ;
TOGA, M .
HUMAN PATHOLOGY, 1986, 17 (04) :355-365
[2]   FIBRONECTIN AND TYPE-III COLLAGEN IN EPITHELIAL NEOPLASMS OF GASTROINTESTINAL-TRACT AND SALIVARY-GLAND [J].
DARDENNE, AJ ;
BURNS, J ;
SYKES, BC ;
BENNETT, MK .
JOURNAL OF CLINICAL PATHOLOGY, 1983, 36 (07) :756-763
[3]   COMPARATIVE DISTRIBUTION OF FIBRONECTIN AND TYPE-III COLLAGEN IN NORMAL HUMAN-TISSUES [J].
DARDENNE, AJ ;
BURNS, J ;
SYKES, BC ;
KIRKPATRICK, P .
JOURNAL OF PATHOLOGY, 1983, 141 (01) :55-69
[4]   PAUCITY OF FIBRONECTIN IN INVASIVE LOBULAR CARCINOMA OF BREAST [J].
DARDENNE, AJ ;
BARNARD, NJ .
JOURNAL OF PATHOLOGY, 1989, 157 (03) :219-224
[5]  
ELSTON CW, DIAGNOSTIC HISPATHOL, P300
[6]  
FOIDART JM, 1980, LAB INVEST, V42, P336
[7]   CELL-SURFACE ANTIGENS OF HUMAN BLADDER-CANCER DEFINED BY MOUSE MONOCLONAL-ANTIBODIES [J].
FRADET, Y ;
CORDONCARDO, C ;
THOMSON, T ;
DALY, ME ;
WHITMORE, WF ;
LLOYD, KO ;
MELAMED, MR ;
OLD, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (01) :224-228
[8]   ELEVATED LEVELS OF THE ALPHA-5-BETA-1-FIBRONECTIN RECEPTOR SUPPRESS THE TRANSFORMED PHENOTYPE OF CHINESE HAMSTER OVARY CELLS [J].
GIANCOTTI, FG ;
RUOSLAHTI, E .
CELL, 1990, 60 (05) :849-859
[9]  
GUSTERSON BA, 1982, CANCER RES, V42, P4763
[10]  
HAND PH, 1985, CANCER RES, V45, P2713